Finance

UBS Upgrades Palantir to Buy on AI Rally, Sees Clear AI Winner

UBS reportedly upgraded Palantir Technologies to Buy from Neutral, calling it a clear AI winner and a buy-the-dip opportunity. The note sticks with a $180 price target and suggests Palantir could rally roughly 32% from the Feb. 27 close of $135.94 as AI-driven data spending accelerates.

UBS Upgrades Palantir to Buy on AI Rally, Sees Clear AI Winner

Key Takeaways

  • UBS upgrades Palantir to Buy from Neutral (per CNBC notes) with a $180 target.
  • Implied upside around 32% from the Feb. 27 close of $135.94.
  • Palantir down ~24% YTD but up ~60% over the past 12 months.
  • Forward metrics: ~50x forward free cash flow (2027); ~70% 2026 revenue growth; 2027 FCF margins in the mid-50s%.
  • This assessment rests on a single analyst note and requires corroboration from multiple sources.

People Involved

  • Karl Keirstead Equity Analyst, UBS

Entities Involved

  • Palantir Technologies, Inc. (PLTR) Technology and data-analytics company
  • UBS Group AG Investment bank and research arm

MarketMoodz Analysis

The upgrade places Palantir at the center of the AI stock rally, framing Palantir as a data- and AI-enabled platform poised to benefit from accelerating AI-related data spend in both government and commercial deployments.

From a valuation perspective, the model implies a high-growth premium with Palantir trading around 50x forward free cash flow (2027) and backed by forecasts of about 70% revenue growth in 2026 and mid-50s% FCF margins in 2027; investors should consider model sensitivity to government-adoption risk and execution cadence.

What to watch next: monitor orders, AI-model adoption rates, and data-spend growth to gauge whether growth drivers materialize; track government and commercial traction and margin progression as Palantir scales its AI-enabled offerings. Also seek corroboration from UBS or other broker views to validate the thesis as part of the AI rally.

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial